EconPapers    
Economics at your fingertips  
 

IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation

Ming Zhao (), Yixin Tan, Qiao Peng, Cancan Huang, Yu Guo, Gongping Liang, Bochen Zhu, Yi Huang, Aiyun Liu, Zijun Wang, Mengying Li, Xiaofei Gao, Ruifang Wu, Haijing Wu, Hai Long and Qianjin Lu ()
Additional contact information
Ming Zhao: Hunan Key Laboratory of Medical Epigenomics
Yixin Tan: Hunan Key Laboratory of Medical Epigenomics
Qiao Peng: Hunan Key Laboratory of Medical Epigenomics
Cancan Huang: Hunan Key Laboratory of Medical Epigenomics
Yu Guo: Hunan Key Laboratory of Medical Epigenomics
Gongping Liang: Hunan Key Laboratory of Medical Epigenomics
Bochen Zhu: Hunan Key Laboratory of Medical Epigenomics
Yi Huang: Hunan Key Laboratory of Medical Epigenomics
Aiyun Liu: Hunan Key Laboratory of Medical Epigenomics
Zijun Wang: Hunan Key Laboratory of Medical Epigenomics
Mengying Li: Hunan Key Laboratory of Medical Epigenomics
Xiaofei Gao: Hunan Key Laboratory of Medical Epigenomics
Ruifang Wu: Hunan Key Laboratory of Medical Epigenomics
Haijing Wu: Hunan Key Laboratory of Medical Epigenomics
Hai Long: Hunan Key Laboratory of Medical Epigenomics
Qianjin Lu: Hunan Key Laboratory of Medical Epigenomics

Nature Communications, 2018, vol. 9, issue 1, 1-14

Abstract: Abstract Epigenetic modifications affect the differentiation of T cell subsets and the pathogenesis of autoimmune diseases, but many mechanisms of epigenetic regulation of T cell differentiation are unclear. Here we show reduced expression of the transcription factor RFX1 in CD4+ T cells from patients with systemic lupus erythematosus, which leads to IL-17A overexpression through increased histone H3 acetylation and decreased DNA methylation and H3K9 tri-methylation. Conditional deletion of Rfx1 in mice exacerbates experimental autoimmune encephalomyelitis and pristane-induced lupus-like syndrome and increases induction of Th17 cells. In vitro, Rfx1 deficiency increases the differentiation of naive CD4+ T cells into Th17 cells, but this effect can be reversed by forced expression of Rfx1. Importantly, RFX1 functions downstream of STAT3 and phosphorylated STAT3 can inhibit RFX1 expression, highlighting a non-canonical pathway that regulates differentiation of Th17 cells. Collectively, our findings identify a unique role for RFX1 in Th17-related autoimmune diseases.

Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-018-02890-0 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-02890-0

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-018-02890-0

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-02890-0